Athenex Buys Kuur Therapeutics – Quick Facts

The Best and Worst States for Retirees

Retirement may be the end of a career, but it’s also the start of a new chapter of adulthood. Most people know when they can or want to retire. Where to retire, however, may be a more complex decision to make.

To rank the best and worst states for people who want to stay active, both physically and socially, in retirement, 24/7 Tempo used data from the U.S. Census Bureau and the Centers for Disease Control and Prevention. We created an index of more than 20 measures of retirement-friendliness, representing four categories — environment, health-related factors, social support, and demographics.

One of the advantages of retirement is that a person is not limited to living in their current state. Many retirees relocate to experience a different way of life in a new environment. It’s hard to look past sunshine, nice weather year-round, as well as a large number of retirement communities and social events. 

To stay happy as well as healthy in older age, it is important that people eat a healthy diet, avoid unhealthy habits like smoking, and get preventive medical care like vaccinations and disease screenings. It’s important that retirees have a good idea of what their cost of living will be so they can make plans, save, and avoid financial hardship. This is what it costs to retire in every state.

Click here to see the best and worst states for retirees
Click here to read our detailed methodology

Hannover Re Q1 Net Income, Premium Up, EBIT Down; Confirms FY21 Outlook; Proposes Dividend

German re-insurer Hannover Re AG (HVRRY.PK,HVRRF.PK) reported Wednesday that its first-quarter Group net income increased 1.7 percent to 305.9 million euros from last year’s 300.9 million euros. Earnings per share amounted to 2.54 euros, up from 2.49 euros last year.

The operating profit or EBIT, meanwhile, contracted 5.3 percent to 403.8 million euros from 426.6 million euros a year ago.

The gross written premium booked by Hannover Re grew 11.9 percent to 7.80 billion euros from prior year’s 6.98 billion euros. Adjusted for exchange rate effects, growth would have amounted to 16.8 percent.

Net premium earned climbed 11.7 percent to 5.7 billion euros from 5.1 billion euros last year. Growth would have reached 16.4 percent at constant exchange rates.

Further, the company confirmed its profit target for fiscal 2021. Hannover Re continues to expect net income in the range of 1.15 billion euros to 1.25 billion euros for the 2021 financial year.

The return on investment is anticipated to be roughly 2.4 percent and Group gross premium is forecast to show growth in the upper single-digit percentages adjusted for exchange rate effects.

The net major loss budget for 2021 is now set at 1.1 billion euros, compared to previous 975 million euros, primarily due to the growth in the underlying business.

The Executive Board and Supervisory Board have proposed an ordinary dividend of 4.50 euros per share for the 2020 financial year.

Veolia Q1 Current Net Income Climbs; Confirms FY21 View; Stock Up

French resource management firm Veolia Environnement (VE) reported Wednesday that its first-quarter current net income group share climbed 54.7 percent to 188 million euros from last year’s 121 million euros.

Excluding capital gains and losses on financial divestitures net of tax, current net income attributable to owners were 186 million euros, compared to 117 million euros a year ago.

Current EBIT was 469 million euros, up 19.6 percent from last year’s 392 million euros. EBITDA increased 11.2 percent from last year to 1.08 billion euros.

Revenue for the quarter was 6.81 billion euros, up 2 percent from 6.68 billion euros a year ago. Revenue grew 4 percent at constant exchange rates and 3 percent at constant scope and exchange rates.

Revenue was also up 2.8 percent at constant forex compared to the first quarter in 2019.

Looking ahead, the company said it is ahead of 2021 objectives and confirmed that 2021 will be a very good year in terms of growth and profits.

Despite continued impact of sanitary crisis in the beginning of the year, Veolia will more than offset 2020 and deliver strong results growth in 2021.

For the year, the company projects EBITDA above 4 billion euros, a growth of more than 10 percent from last year, and revenue above 2019.

The company also plans to recover the pre-crisis dividend policy in 2021

In Paris, Veolia shares were trading at 26.40 euros, up 1.54 percent.

SIG Plc: YTD Performance Ahead Of Expectations

SIG plc (SHI.L) issued a trading update for 1 January to 30 April 2021. The Group said its performance for the year to date has been ahead of expectations. Group sales were 29% up on 2020 for the four-month period. The Group now expects to deliver an underlying operating profit in the first half, returning the Group to profitability earlier than expected.

SIG plc said it continues to expect the second half to be both profitable and cash generative. The Group now expects full year revenues to be slightly ahead of prior expectations, and profits also to be higher than previously expected.

Late Night Has a New Contender for Weirdest Presidential Photo Ever

The Bidens visited the Carters the other day, and Jimmy Fallon, Seth Meyers and Trevor Noah are still trying to get their minds around the result.

By Trish Bendix

Athenex Buys Kuur Therapeutics – Quick Facts

Athenex, Inc. (ATNX) has acquired Kuur Therapeutics, Inc., a developer of off-the-shelf CAR-NKT cell immunotherapies for the treatment of solid and hematological malignancies. Kuur Therapeutics is a IP Group plc – Portfolio company. Athenex will pay $70 million upfront to Kuur shareholders and certain of its former employees and directors, comprised primarily of equity in Athenex common stock. Additionally, they are eligible to receive up to $115 million of milestone payments.

Johnson Lau, Chief Executive Officer of Athenex, said: “We are excited to add Kuur Therapeutics and its innovative allogeneic CAR-NKT technology to the Athenex platform. Kuur’s innovative technology, combined with our TCR program, could propel us into a leadership position in cell therapy.”

Also, NeoGenomics, Inc (NEO) has agreed to acquire Inivata, a IP Group plc – Portfolio company. IP Group will receive approximately $91 million in cash or, potentially, NeoGenomics stock, at the Group’s election. Current Inivata CEO Clive Morris will become the President of Inivata and will report to Mark Mallon, CEO of NeoGenomics.